您的当前位置:首页 > 行业数据 > 图4.国内基于辉瑞的Danuglipron技术路线布局GLP-1小分子的企业-2
图片属性
图片格式:PNG 图片大小:397KB 图片尺寸:2338*1211
同报告图片
 / 4
图4.国内基于辉瑞的Danuglipron技术路线布局GLP-1小分子的企业-2_第1页
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
图4.国内基于辉瑞的Danuglipron技术路线布局GLP-1小分子的企业-2_第2页
图4.国内基于辉瑞的Danuglipron技术路线布局GLP-1小分子的企业-2_第3页
图4.国内基于辉瑞的Danuglipron技术路线布局GLP-1小分子的企业-2_第4页
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
图4.国内基于辉瑞的Danuglipron技术路线布局GLP-1小分子的企业-2_第5页
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
所属报告: 生物医药行业创新药研究框架之GLP~1:内卷时代更看好小分子、多靶点、长效三大方向差异化突破-240816(33页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠